| HER-2/neu | Test significance | |||
Positive | Negative | ||||
Number | % | Number | % | ||
Age |
|
|
|
|
|
<50 | 10 | 47.6 | 21 | 42.0 | 0.19† P = 0.430 |
≥50 | 11 | 52.4 | 29 | 58.0 | |
Sex |
|
|
|
|
|
Male | 14 | 66.7 | 27 | 54.0 | 0.432† P = 0.236 |
Female | 7 | 33.3 | 23 | 46.0 | |
Histologic type |
|
|
|
|
|
Intestinal | 17 | 81.0 | 37 | 74.0 | 1.155‡ P = 0.561 |
Diffuse | 3 | 14.3 | 12 | 24.0 | |
Mixed | 1 | 4.8 | 1 | 2.0 | |
Histologic grade |
|
|
|
|
|
Moderately differentiated | 12 | 57.1 | 30 | 60.0 | 0.05† P = 0.514 |
Poorly differentiated | 9 | 42.9 | 20 | 40.0 | |
Pathologic tumor stage |
|
|
|
|
|
T1, T2 | 1 | 4.8 | 12 | 24.0 | 4.95‡ P = 0.026* |
T3, T4 | 20 | 95.2 | 38 | 76.0 | |
Lymph node metastasis |
|
|
|
|
|
Present | 16 | 76.2 | 34 | 68.0 | 0.476† P = 0.348 |
Absent | 5 | 23.8 | 16 | 32.0 | |
Pathologic nodal stage |
|
|
|
|
|
N0 N1 N2 N3 | 5 2 8 6 | 23.8 9.5 38.1 28.6 | 16 10 10 14 | 32.0 20.0 20.0 28.0 | 3.208† P = 0.361 |
Number of nodes with metastasis |
|
|
| ||
Range Median | 0 - 14 4.5 | 0 - 27 5.5 | 0.24§ P = 0.625 | ||
Lymphovascular invasion |
|
|
| ||
Present | 19 | 90.5 | 32 | 64.0 | 5.12‡ P = 0.020* |
Absent | 2 | 9.5 | 18 | 36.0 |